The Penn State Hershey Institute for Personalized Medicine benefits from a unique “build it as you need it” growth pattern

Penn Medicine’s Center for Personalized Diagnostics is on a mission to improve patient care using the power of genomics

How is fierce ambition translated into the reality of building two world-class personalized healthcare institutes?

Patient-derived xenografts are a valuable tool for the oncological drug development of the future

Newborn screening programs that seek out common mutations often fail to diagnose cystic fibrosis in nonwhite populations.

Shotgun sequencing is a powerful tool in microbial genomics, but viral genomes have proven tough to crack.

Hirschsprung disease (HSCR) is a congenital form of megacolon that occurs when the ganglion cells of the digestive tract fail to develop, impairing or eliminating function.

Around the world, use of digital pathology is becoming increasingly common.

The diagnosis of cancers at an early stage is critical for the long-term survival of patients.

This paper is one of a number published over the last year that examine the potential for liquid biopsy in colorectal cancer.